 Your new post is loading...
Your new post is loading...
|
Scooped by
HAS-veille
June 21, 2023 9:49 AM
|
Objectifs : Établir un état des lieux de la vaccination des étudiants en santé de l’université Lyon 1 et évaluer la mise en place d’un nouveau dispositif de vérification des obligations d’immunisation à l’aide du carnet de vaccination électronique (CVE) MesVaccins.net. Méthodes : Questionnaire envoyé par le Service de santé universitaire (SSU) de Lyon 1 aux étudiants majeurs en première année de santé en 2020-2021 ayant partagé leur CVE ; exploitation des données de ces CVE. Résultats : Les étudiants étaient 67,4 % à avoir transmis leurs informations au SSU. Ils ont rapporté des difficultés organisationnelles pour se mettre à jour (33,3 %) et pour faire valider leur CVE par un professionnel de santé (55,9 %). La satisfaction globale des étudiants vis-à-vis de ce dispositif était de 78,0 %. Cette étude a mis en avant plusieurs différences entre les campus de Lyon Est et Lyon Sud, notamment sur la connaissance du SSU, la visibilité de la campagne, le pourcentage d’étudiants qui ont transmis leurs informations et le pourcentage d’étudiants à jour. Concernant les immunisations obligatoires, 83,4 % des étudiants étaient à jour du vaccin diphtérie-tétanos-poliomyélite, 56,8 % de l’hépatite B et 64,7 % avaient pratiqué une intradermoréaction ; 43,4 % des étudiants étaient à jour simultanément de ces trois immunisations. Conclusion : Le pourcentage d’étudiants à jour est insuffisant. Cette étude souligne la nécessité d’une campagne précoce de promotion des immunisations avec un meilleur accès des étudiants à des professionnels de santé validant les CVE.
|
|
Scooped by
HAS-veille
June 21, 2023 4:07 AM
|
|
|
Scooped by
HAS-veille
June 20, 2023 1:37 AM
|
How much does endorsement of complementary and alternative medicine (CAM) correlate with negative attitudes towards vaccines? One of the difficulties …
|
|
Scooped by
HAS-veille
June 15, 2023 7:45 AM
|
|
|
Scooped by
HAS-veille
June 15, 2023 4:03 AM
|
Literature is limited on the impact of patient vaccination on the risk of hospital-acquired influenza (HAI). This test negative case-control study nes…
|
|
Scooped by
HAS-veille
June 14, 2023 3:48 AM
|
VLA1553 is a live-attenuated vaccine candidate for active immunisation and prevention of disease caused by chikungunya virus. We report safety and imm…
|
|
Scooped by
HAS-veille
June 9, 2023 12:57 AM
|
Pregnant women are often at higher risk for morbidity and mortality due to contracting vaccine-preventable diseases that result in adverse pregnancy o…
|
|
Scooped by
HAS-veille
June 8, 2023 10:46 AM
|
|
|
Scooped by
HAS-veille
June 7, 2023 3:50 AM
|
Analysis of nearly 300,000 people finds an association between the shingles jab and a lower rate of dementia — but questions linger.
|
|
Scooped by
HAS-veille
June 5, 2023 1:45 AM
|
Vast quantities of open-source data from news reports, social media and other sources can be harnessed using artificial intelligence and machine learn…
|
|
Scooped by
HAS-veille
June 1, 2023 9:17 AM
|
The Food and Drug Administration approved a second vaccine to protect older adults against RSV on Wednesday, giving a green light to Pfizer’s Abrysvo for adults 60 and older.
|
|
Scooped by
HAS-veille
May 31, 2023 8:26 AM
|
Increasing vaccine hesitancy and refusal poses a challenge to public health as even small reductions in vaccine uptake can result in large outbreaks o…
|
|
Scooped by
HAS-veille
May 30, 2023 10:42 AM
|
The study estimated that an average of 245,244 children under 5 years are hospitalized annually due to RSV in the EU, with the highest hospitalization rates in
|
|
|
Scooped by
HAS-veille
June 21, 2023 7:38 AM
|
Despite vaccine availability, influenza remains a substantial global public health concern. Here, we report interim findings on the primary and secondary objectives of the safety, reactogenicity, and humoral immunogenicity of a quadrivalent messenger RNA (mRNA) vaccine against seasonal influenza, mRNA-1010, from the first 2 parts of a 3-part, first-in-human, phase 1/2 clinical trial in healthy adults aged ≥18 years (NCT04956575). In the placebo-controlled Part 1, a single dose of mRNA-1010 (50 µg, 100 µg, or 200 µg) elicited hemagglutination inhibition (HAI) titers against vaccine-matched strains. In the active-comparator-controlled Part 2, mRNA-1010 (25 µg, 50 µg, or 100 µg) elicited higher HAI titers than a standard dose, inactivated seasonal influenza vaccine for influenza A strains and comparable HAI titers for influenza B strains. No safety concerns were identified; solicited adverse reactions were dose-dependent and more frequent after receipt of mRNA-1010 than the active comparator. These interim data support continued development of mRNA-1010. Here the authors report initial findings of a phase 1 clinical trial, showing that an investigational, mRNA-based vaccine for seasonal influenza (mRNA-1010) has no safety concerns and produces immune responses in adults that are similar or higher than a licensed comparator vaccine.
|
|
Scooped by
HAS-veille
June 21, 2023 3:42 AM
|
It has been proven that vaccination is effective against Human Papillomavirus (HPV) infections, genital warts, and pre-cancerous and cancerous cervica…
|
|
Scooped by
HAS-veille
June 19, 2023 1:52 AM
|
Recently, studies have suggested that influenza antibody titers decline with time since vaccination. Duration of vaccine protection is an important fa…
|
|
Scooped by
HAS-veille
June 15, 2023 4:42 AM
|
Introduction
Despite various efforts to improve human papillomavirus (HPV) vaccine coverage in France, it has always been lower than in most other high-income countries. The health authoritie
|
|
Scooped by
HAS-veille
June 15, 2023 4:01 AM
|
Immunization is essential for safeguarding health workers from vaccine-preventable diseases (VPDs) that they may encounter at work; however, informati…
|
|
Scooped by
HAS-veille
June 12, 2023 7:08 AM
|
This report describes polio surveillance targets and gaps in countries experiencing high risk for poliovirus transmission.
|
|
Scooped by
HAS-veille
June 9, 2023 12:56 AM
|
The epidemiology of circulating seasonal influenza strains changed following the 2009 pandemic influenza A(H1N1). A universal influenza vaccination re…
|
|
Scooped by
HAS-veille
June 8, 2023 10:15 AM
|
Bien que l’infection invasive à méningocoque soit endémique en Amérique du Nord, le Québec a vécu trois épisodes épidémiques depuis 1990, chacun ayant abouti à d’importantes campagnes de vaccination. Le méningocoque de sérogroupe C a été impliqué dans deux de ces épisodes qui ont généré une forte anxiété dans la population et entraîné d’importantes turbulences dans le système de santé.
|
|
Scooped by
HAS-veille
June 5, 2023 5:47 AM
|
Vaccine-related medication errors can occur at each step of the vaccination process: prescribing, dispensing, preparation, administration, monitoring,…
|
|
Scooped by
HAS-veille
June 5, 2023 1:35 AM
|
The universal introduction of PCV7, and later PCV13, for children 0–59 months old in the United States was associated with decreases in mortality due to all-caus
|
|
Scooped by
HAS-veille
June 1, 2023 9:13 AM
|
By summarizing evidence from 14 studies, we reported strong HPV vaccine efficacy/effectiveness against anal HPV infection and anal intraepithelial neoplasia (AI
|
|
Scooped by
HAS-veille
May 31, 2023 7:42 AM
|
Antimicrobial resistance (AMR) is a global public health threat causing substantial morbidity and mortality as well as significant economic costs. Vaccines can contribute to combatin
|
Scoop.it!
